DMCC Q3 results: revenue up 28%, profit down 22%; CEO re-appointed for 3 years
DMCC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 0.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
DMCC Speciality Q3 FY26 revenue grew 28% to Rs 15,083 lakhs but net profit fell 22% to Rs 616 lakhs due to higher raw material costs. For 9M FY26, revenue rose 32% to Rs 40,367 lakhs and net profit grew 30% to Rs 1,967 lakhs. Board re-appointed Bimal Goculdas as MD and CEO for 3 years from April 2026 and approved MOA and AOA amendments, subject to shareholder approval through postal ballot.
Mixed Q3 with margin pressure despite strong revenue growth; CEO continuity confirmed. MOA and AOA changes need shareholder approval via postal ballot.